Literature DB >> 15009825

Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders.

Mei-Chun Hsiao1, Cheng-Cheng Hsiao, Chia-Yih Liu.   

Abstract

The aim of the present study was to examine the frequencies of premenstrual syndrome (PMS) and premenstrual exacerbation (PME) of a number of psychiatric disorders in Chinese subjects. Premenstrual syndrome was assessed using a symptom checklist based on International Classification of Diseases (10th revision; ICD-10) criteria. Premenstrual exacerbation was defined as premenstrual worsening of pre-existing generalized anxiety disorder (GAD), major depressive disorder or dysthymic disorder (depressive disorders, DD), panic disorder (PD), or schizophrenia (SCH). Fifty outpatients were randomly sampled for each diagnostic group. Diagnosis was performed by psychiatrists using the structured Mini-International Neuropsychiatric Interview (MINI), and the frequencies of PMS and PME were compared for the different diagnostic groups. The PMS symptoms were reported by 78%, 80%, 68%, and 52% of GAD, DD, PD, and SCH patients, respectively, with 52%, 52%, 36%, and 20% fulfilling the definition of PME. No significant statistical relationships between diagnostic entities and family history of PMS, years of education, or age were demonstrated, but number of PMS symptoms was associated with severity of PME. No significant relationships were demonstrated between PME and marital status, parity, years of education, age, or family history of PMS. The results showed that high PME rates were noted for a sample of Chinese women with mental disorders, especially those with depressive and anxiety disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15009825     DOI: 10.1111/j.1440-1819.2003.01215.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  9 in total

1.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

2.  Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology.

Authors:  Eynav E Accortt; Anya V Kogan; John J B Allen
Journal:  J Affect Disord       Date:  2013-06-22       Impact factor: 4.839

Review 3.  Menstrual cycle-related exacerbation of disease.

Authors:  Joann V Pinkerton; Christine J Guico-Pabia; Hugh S Taylor
Journal:  Am J Obstet Gynecol       Date:  2010-03       Impact factor: 8.661

Review 4.  Startling Differences: Using the Acoustic Startle Response to Study Sex Differences and Neurosteroids in Affective Disorders.

Authors:  Liisa Hantsoo; Carla E M Golden; Sara Kornfield; Christian Grillon; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2018-05-18       Impact factor: 5.285

5.  Anxiety Disorders Among Women: A Female Lifespan Approach.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Focus (Am Psychiatr Publ)       Date:  2017-04-10

6.  Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders.

Authors:  Yoshiko Miyaoka; Yoshie Akimoto; Kayoko Ueda; Yuri Ujiie; Machiko Kametani; Yoko Uchiide; Toshiko Kamo
Journal:  Biopsychosoc Med       Date:  2011-05-02

7.  Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis.

Authors:  Thomas J Reilly; Vanessa C Sagnay de la Bastida; Dan W Joyce; Alexis E Cullen; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 8.  Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone.

Authors:  Lindsay R Standeven; Elizabeth Olson; Nicole Leistikow; Jennifer L Payne; Lauren M Osborne; Liisa Hantsoo
Journal:  Curr Psychiatry Rep       Date:  2021-04-21       Impact factor: 5.285

Review 9.  Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review.

Authors:  Ariel B Handy; Shelly F Greenfield; Kimberly A Yonkers; Laura A Payne
Journal:  Harv Rev Psychiatry       Date:  2022 Mar-Apr 01       Impact factor: 3.732

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.